Checkpoint+: Improving Access to HIV Prevention and Early Diagnosis Among Migrant Men Who Have Sex With Men, Trans People, and Non-binary People (CHECKPOINT+)

November 9, 2026 updated by: Felix Perez Tejera

Checkpoint+ is a community-based observational study designed to better understand barriers to HIV prevention, early diagnosis, and sexual health care among migrant men who have sex with men, trans people, and non-binary people. The study collects information on participants' migration experiences, access to health services, perceived barriers, and suggestions for improving culturally appropriate and accessible HIV and sexual health services.

Based on the proposals made by the community, a set of community-based interventions will be selected and implemented to encourage more migrant MSM, trans and non-binary people to access BCN Checkpoint for the first time for HIV testing and other sexual health services. The interventions will then be evaluated, and the most successful ones will be implemented again to maximise their impact.

Study Overview

Detailed Description

Checkpoint+ is a community-based research study promoted by Projecte dels NOMS - Hispanosida / BCN Checkpoint. The study focuses on understanding the experiences, needs, and perceived barriers of migrant men who have sex with men, trans people, and non-binary people in relation to HIV prevention, early diagnosis, and broader sexual health care.

The study aims to generate evidence that can help improve access to routine HIV testing, prevention services, and sexual health care for migrant communities. It also seeks to identify participant-informed recommendations for designing more accessible, effective, and culturally appropriate interventions, including awareness campaigns, outreach activities, and service-delivery strategies adapted to the realities of people with diverse migration experiences.

Participation includes an anonymous survey exploring migration history, experiences with health services, perceived barriers to sexual health care, HIV and STI testing, access to information, and proposals for improving services for people with similar backgrounds and needs. Participants may also indicate whether they are willing to be contacted for an optional individual interview, intended to explore personal experiences, opinions, and recommendations in greater depth.

Following the survey and interview phases, the research team, together with the Community Advisory Committee, will select a sample of community-based interventions proposed by participants. These interventions will be implemented with the aim of increasing the number of migrant MSM, trans and non-binary people who access BCN Checkpoint for the first time for HIV testing and other sexual health services. Their impact will be evaluated using aggregated service indicators and information on how first-time users learned about BCN Checkpoint. The most successful interventions will then be implemented again in order to maximise their overall impact and inform future replicability.

The information collected will be analysed in aggregate and anonymised form. Findings may be used to inform community-based HIV prevention and early diagnosis programmes, support the development of more inclusive sexual health services, and contribute to scientific dissemination through publications, conference presentations, reports, and other materials. As a final output, the study will also inform the development of a Good Practice Guide to promote HIV prevention and early diagnosis among migrant MSM, trans and non-binary people.

Study Type

Observational

Enrollment (Estimated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Barcelona, Spain, 08015
        • Recruiting
        • BCN Checkpoint

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population consists of migrant men who have sex with men, trans people, and non-binary people aged 18 years or older who were born outside Spain and currently live in Catalonia. Participants will be recruited through BCN Checkpoint and through community-based and health-related channels, including printed and digital study materials distributed in community organisations, venues, social media, and collaborating services.

Description

Inclusion Criteria:

  • Aged 18 years or older.
  • Self-identifies as MSM, ar a trans/non-binary person.
  • Born outside Spain and currently living in Catalonia.
  • Able and willing to provide written informed consent.
  • Able to communicate in one of the study languages.

Exclusion Criteria:

  • Not meeting one or more of the inclusion criteria.
  • Individuals who, at the time participation may be proposed, are considered by the study staff to have significantly impaired judgement, orientation, or understanding due to substance use or other circumstances, such as acute intoxication or severe physical or psychological distress requiring urgent medical or psychiatric care.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: ECOLOGIC_OR_COMMUNITY
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort
Migrant MSM, trans and non-binary people

Migrant men who have sex with men, trans people, and non-binary people participating in a community-based observational study on barriers to HIV prevention, early diagnosis, and access to sexual health services. Participants complete an anonymous survey and may optionally take part in an individual interview. Community-based interventions proposed by participants will later be selected, implemented, evaluated, and reimplemented if successful, with the aim of increasing first-time access to BCN Checkpoint for HIV testing and other sexual health services.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived barriers to HIV testing and sexual health service access
Time Frame: At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment

Participant-reported barriers to HIV testing, HIV prevention, and access to sexual health services, collected through the anonymous survey and optional qualitative interviews.

At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment
Community proposals for improving access to HIV prevention and early diagnosis
Time Frame: At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment

Participant-reported proposals for improving access to HIV testing, HIV prevention, and sexual health services among migrant MSM, trans and non-binary people, collected through the anonymous survey and optional qualitative interviews.

At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of first-time migrant MSM, trans and non-binary users accessing BCN Checkpoint
Time Frame: Assessed at the end of the second project year

Number of migrant men who have sex with men, trans people, and non-binary people who access BCN Checkpoint for the first time for HIV testing or other sexual health services during the intervention period. This indicator will be analysed using aggregated BCN Checkpoint service data and compared with a historical monthly baseline from previous years.

Assessed at the end of the second project year
Number of new HIV diagnoses among migrant MSM, trans and non-binary people
Time Frame: Assessed at the end of the second project year

Number of new HIV diagnoses identified at BCN Checkpoint among migrant MSM, trans and non-binary people during the intervention and reimplementation period, using aggregated service indicators.

Assessed at the end of the second project year
Sources of first-time access to BCN Checkpoint
Time Frame: Assessed at the end of the second project year

Self-reported source through which first-time users learned about BCN Checkpoint, collected to estimate which community-based interventions contributed most to new first-time visits.

Assessed at the end of the second project year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

June 4, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the study collects sensitive information on migration history, sexual orientation and/or gender identity, HIV status, sexual health, stigma, and access to care. Results will be reported only in aggregate and anonymised form to minimise any risk of participant re-identification.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe